William F. Daniel - Apr 28, 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
Director
Signature
/s/ Meghanne Downes, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Apr 28, 2023
Transactions value $
-$208,870
Form type
4
Date filed
5/2/2023, 07:24 PM
Previous filing
May 2, 2022
Next filing
Jul 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +3.91K +13.1% 33.8K Apr 28, 2023 Direct F1, F2
transaction HZNP Ordinary Shares Tax liability -$209K -1.88K -5.56% $111.16 31.9K Apr 28, 2023 Direct
holding HZNP Ordinary Shares 47.7K Apr 28, 2023 By Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units Options Exercise $0 -3.91K -100% $0.00* 0 Apr 28, 2023 Ordinary Shares 3.91K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
F2 29,881 Ordinary Shares previously reported as held by Trust held directly.